InsidersTradesSigma
Track the 에스디생명공학 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에스디생명공학 has published 1 public disclosures. Market capitalisation: €52.6bn. The latest transaction was filed on 24 March 2026 (Sale). Among the most active insiders: 수성자산운용. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,322 of 29,064 companies
24.9
score / 100
Value15
Quality35
FCF yld-9.9%
Earn yld-14%
EV/EBITDA·
ROE·
Gross mgn45%
Net mgn-24%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 March 2026
关于 에스디생명공학
에스디생명공학 是一家在XKRX市场上市的医疗保健和制药公司。该公司专注于开发创新的生物制药解决方案。